Clinical Data on Janssen’s Simeprevir for HCV to Feature at International Liver Congress
Hepatitis C, News
Janssen Sciences Ireland UC is going to present clinical data regarding its NS3/4A protease inhibitor, called simeprevir, to treat hepatitis C virus (HCV) infections at the upcoming International Liver Congress 2015. The ... Read more